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Diabetes represents a major global health problem. It was estimated that the global prevalence of diabetes in 
2019 was approximately 9%, with the worrying projection to increase up to 11% by 2045 [1]. Importantly, 
it was also calculated that in 2016 worldwide nearly 1.6 million deaths were directly related to diabetes 
or high blood glucose [1]. In parallel, other important endocrinological diseases, such as obesity, thyroid 
diseases (i.e., hyperthyroidism, hypothyroidism, and cancer), polycystic ovary syndrome, and infertility, have 
a relevant clinical and socio-economic impact worldwide [2, 3]. These data strongly suggest that an additional 
uplift in research efforts is necessary in this area.
Over the last years, bibliometric studies have been performed in order to evaluate the research 
productivity and quality of different countries in many scientific fields [4]. However, updated information 
on the scientific productivity and quality of different countries in the Endocrinology and Diabetology field is 
lacking. Therefore, the main aims of this report were: (a) to compare the publication productivity of scientific 
research in the Endocrinology and Diabetology field among various countries in a sufficient period of time; 
(b) to put in relation the scientific productivity of various countries with their gross domestic product (GDP, 
which is the monetary value of all finished goods and services made within a country during a specific 
period and provides an economic snapshot of a country [5]), the percentage of GDP spent in research and 
development and the number of researchers per million people; and (c) to compare the quality of scientific 
research among various countries using the citation counts and total H-index (that can be used as indirect 
markers of research quality). Information regarding the publication productivity was obtained by the SCImago 
website [6]. Briefly, SCImago is an online platform that ranks journals and countries in several fields based 
on various bibliometric markers, including total documents per year, citable documents, cites per document, 
and H-index. The ranking is performed using Elsevier’s subscription-based Scopus database. Specifically, 
we obtained the aforementioned information in the Endocrinology and Diabetology field between 1996 
and 2018. For such period, we also acquired information regarding the GDP, the percentage of GDP spent 
in research and development, and the number of researchers per million people for various countries by 
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the World Bank Group website [7]. The main bibliometric and economic parameters for 173 countries are 
reported in Supplementary Table 1.
Figure 1 reports the comparison of outputs of endocrinology and diabetes research papers among the 
top eight countries, between 1996 and 2018, in relation to the GDP (Figure 1A), the percentage of GDP spent 
in research and development (Figure 1B), the number of researchers per million people (Figure 1C) and the 
citation counts (Figure 1D). As reported in Figure 1A, from 1996 to 2018, the USA was the leader regarding 
the outputs of endocrinology and diabetes research papers in relation to their GDP, followed by the UK, Italy, 
Germany, Japan, France, Canada, and China. Interestingly, when compared to other countries, Italy had one 
of the highest outputs of endocrinology and diabetes research papers with one of the lowest GDP. Respecting 
the percentage of GDP spent in research and development, from 1996 to 2018, Italy was also one of the main 
scientific producers of research papers in the Endocrinology and Diabetology field with one of the lowest 
percentage of GDP spent in research and development (Figure 1B). Similar considerations can be done for the 
outputs of endocrinology and diabetes research papers in relation to the number of researchers per million 
people (Figure 1C) and citation counts (Figure 1D).
Figure 2 shows the trend in terms of the outputs of endocrinology and diabetes research papers, between 
2010 and 2018, for top 5 countries. Again, the USA was the leader regarding the outputs of endocrinology 
and diabetes research papers over time. Notably, China was the country that has had a significant increase 
in scientific productivity in the field of endocrinology and diabetes in the period under consideration, while 
Italy was in the top four positions, preceded only by the USA, the UK, and China.
The scatterplot matrices of principal bibliometric and economic parameters in 173 countries regarding 
the outputs of Endocrinology and diabetes research between 1996 and 2018 is reported in Figure 3.
From our report, it clearly emerges that the quantity (i.e., total documents) and quality (i.e., citations 
and total H-index) of the Endocrinology and diabetes research are broadly associated with GDP, percentage 
of GDP spent in research and development and the number of researchers for million people for most 
countries, with important exceptions. One of these is certainly Italy. In fact, the quantity and quality of science 
produced in Italy in the Endocrinology and Diabetology field are relatively higher than expected, especially 
considering the percentage of GDP spent in research and development and the number of researchers per 
million people of this country. Indirectly, this fact displays the excellent preparation and inventiveness of 
Italian researchers. In other words, Italy still occupies a relevant position on the international scientific 
panorama in the Endocrinology and Diabetology field, with considerable efficiency and quality in scientific 
production, despite numerous difficulties. Among them, it is important to remember that, in our country, the 
number of researchers is still small [8, 9], academic hiring practices is often complicated, many researchers 
tend to expatriate or abandon their research, public research funding is often insufficient, there is a lack of 
flexibility and immediacy in the availability of resources and an absence of long-term planning, the economic 
management of funding is made difficult by an excess of bureaucratization and incomprehensible rules [10], 
and, lastly, the allocation of funding is not fully respectful of merit [11, 12]. In contrast to other countries, 
Italy has failed to modernize its scientific system [11, 12]. This situation is destined to collapse over time, but 
it may be also an opportunity [11, 12]. Along with other researchers [11, 12], in fact, we believe that some 
important reforms are urgently needed, such as an independent, public research foundation that supports 
centers of excellence as part of the European and international network, the reduction of bureaucracy and 
unjustified rules, the distribution of public funds to the universities based on the performance of the teaching 
and the research faculty that should be assessed independently.
Our updated results are substantially in line with some previous studies [4, 13]. For instance, in 2015, 
analyzing a total of 79, 394 articles published on Endocrinology and metabolism from 2010 to 2014, Zhao 
et al. [13] reported that authors in the USA published the most articles, followed by China, Italy, the UK, and 
Japan. In addition, in that study, a positive correlation between the number of publications and GDP was 
observed [13].





Figure 1. Outputs of endocrinology and diabetes research papers among the top eight countries, between 1996 and 2018, in 
relation to the mean GDP (A), the percentage of GDP spent in research and development (B), the number of researchers per 
million people (C) and the citation counts (D)
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Our report has important limitations. First, for many countries in which the main language of publication 
is not English, clinical research articles may be under-represented in the bibliographic databases [4]. Hence, a 
potential language bias may not be excluded completely [4]. Second, we were unable to evaluate the specific 
research article funds in the Endocrinology and Diabetology field for each country. Third, we have not 
specifically addressed the potential impact of each research, with the exception of the citation counts and 
total H-index that have, however, some important limits [4, 14, 15].
In conclusion, our report documents that, for most countries, the quantity and quality of science are 
largely linked to some specific economic parameters, such as the GDP and the percentage of GDP spent in 
research and development, but also to the number of researchers for million people. However, in this regard, 
there are important peculiarities. One of them is surely Italy. The quantity and quality of science produced in 
Italy in the Endocrinology and diabetology filed are relevant, despite numerous impediments that researchers 
have to face every day. Given that the work of researchers is crucial to guaranteeing an adequate technological 
and cultural innovation that represents one of the main drivers of all modern and civil societies, a significant 
boost in the modernization of scientific system in most countries (including Italy) is urgently required.
Figure 2. Trends in the outputs of endocrinology and diabetes research papers, between 2010 and 2018, for the top five countries
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Figure 3. Scatterplot matrices of bibliometric and economic parameters in 173 countries regarding the outputs of endocrinology 
and diabetes research from 1996 to 2018
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